Neurorehabilitation Devices Market

Rapid Technological Advances to boost market growth

During the forecast period, significant technology advancements and the rapid increase in the world's aging population will also contribute to market expansion. The prevalence of neurological conditions like Parkinson's disease and multiple sclerosis is expected to rise, restricting patient mobility, and fueling market expansion. Additionally, the market for brain rehabilitation devices is expanding due to the aging population's rapid increase and the effectiveness of gaming systems in neural rehabilitation. A faster rate of development will ensure that industry growth will be strong during the forecast period.

Increased rates of neurological illnesses, greater patient and care provider awareness, and an increase in the target patient population are the main drivers of the industry's expansion. ly, the senior population is growing, which has raised the frequency of age-related neurological illnesses and, in turn, the prevalence of movement impairments. The demand for adequate and effective neuro-rehab tools and services is expected to rise. Some neurological diseases cannot be fully cured or do not currently have effective treatments. In these situations, neurorehabilitation can save patients and enables them to perform daily tasks.

In recent years, these services have seen major adjustments, which are expected to fuel the growth of the neurorehabilitation devices market during the forecast period.  

Recent studies from the WHO indicate that the number of those 65 and older is predicted to increase from 7% in 2000 to 16% in 2050. According to data released by the UN in 2012, there will be 1.13 billion older people worldwide by 2022. The aging population is more susceptible to age-related neurological diseases like Parkinson's disease as their immune systems are weaker. As a result, during the projected period, the market for neurorehabilitation devices will expand due to the growing base of an older population.

The need for neurorehabilitation equipment is expected to rise in Asian nations like Japan, China, and India due to an aging population and significant untapped potential. The most frequent symptom of neurological disorders is immobility. Stroke is the largest cause of disability in the US and the fifth highest cause of death, according to the American Stroke Association. Multiple sclerosis affects about 2.5 million people worldwide, but Parkinson's disease affects 10 million. These factors are expected to widen the market CAGR across the globe in the recent years.

The utilization of electronic robotic and computer-aided apparatus has significantly altered neurorehabilitation in recent years. These tools help improve how well patients respond to therapeutic interventions for rehabilitation. The sector has great growth potential because neurological disorders are becoming more common. This is another factor driving the growth of the neurorehabilitation devices market revenue.

Significant technological developments and the quickening rate of global population aging will both support market growth during the predicted period. Parkinson's disease and multiple sclerosis are two neurological disorders that are predicted to become more common, limiting patient movement and driving market growth. One of the main factors propelling market expansion is the rise in demand for neurorehabilitation equipment. The market for brain rehabilitation equipment is also growing as a result of the rapidly rising elderly population and the success of gaming systems in neural rehabilitation. Faster development will guarantee sustained industry growth over the foreseeable period.

It is anticipated that there will be a greater need for adequate and efficient neuro-rehab technologies and services. Some neurological conditions are either not currently treatable or incurable. Neurorehabilitation can help patients in these circumstances and restore their ability to carry out regular chores. These services have seen significant changes recently, which are anticipated to drive the market for neurorehabilitation devices to develop throughout the forecast period.  

Rising awareness about the benefits of neurorehabilitation devices, as well as the increasing incidence of neurological conditions like stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury, are all factors that contribute to the expansion of the neurorehabilitation market. The neurorehabilitation market is expanding due to a number of factors, including rising R&D spending and an increase in product approvals of neurorehabilitation devices from regulatory bodies.

February 2023: The pharmaceutical company Lupin plans to house a variety of neuro-rehabilitation services under one roof at its Atharv Ability center, marking the third services-related venture it has launched in just over a year. While reviewing the neurology field, a need gap was discovered due to patient outcomes and neurological illnesses' high rates of morbidity and disability. With a variety of rehabilitation programs for post-stroke patients, patients with traumatic brain injury, spinal cord injury, paediatric neurological conditions, Parkinson's, cerebral palsy, and multiple sclerosis, the multi-disciplined robotic and computer-assisted center may be the only one of its kind in India.

For example, in May 2023, the University of Calgary, in collaboration with Alberta Health Services, launched the Researching Strategies for Rehabilitation (RESTORE) Network, which will conduct clinical trials and new treatments to improve quality of life for people with neurological diseases.

For instance, in April 2023, Sensoria Health partnered with Padula Rehabilitation Technologies (PRT) and released NeurOpTrek – a cutting-edge wearable device that improves vision and helps reduce fall risk among the elderly who are prone to such health conditions.

For example, in February 2023, MindMaze introduced Izar, a completely new tool that has been recently made accessible to both United States as well as some European countries such as Switzerland, Germany and France. The aim of this device is to assist PD patients during their hand function assessment.

In addition to this, Neurofenix secured EUR7 million capital investment from UK investors, thus enabling it to extend its product line and start US-based testing in April 2022. Through the patient-centric approach taken by a company toward at-home rehabilitation programs that have proved more supportive and engaging than traditional alternatives.

The Global Neurorehabilitation Devices Market Industry is projected to experience robust growth over the next decade. With a market value of 0.86 USD Billion in 2024, it is anticipated to expand to 1.76 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 6.72% from 2025 to 2035. Such projections indicate a strong upward trajectory, driven by factors such as technological advancements, increasing prevalence of neurological disorders, and supportive government policies. The market's expansion reflects the growing recognition of the importance of neurorehabilitation in improving patient outcomes.

Government initiatives aimed at improving healthcare infrastructure and funding for rehabilitation services are pivotal for the Global Neurorehabilitation Devices Market Industry. Many countries are increasing their healthcare budgets to address the needs of patients with neurological conditions. For instance, various national health programs are being implemented to support research and development in neurorehabilitation technologies. This financial backing not only promotes innovation but also ensures accessibility for patients requiring these devices. Such initiatives are expected to bolster market growth, contributing to the overall expansion of the industry.

The rising incidence of neurological disorders globally is a primary driver for the Global Neurorehabilitation Devices Market Industry. Conditions such as stroke, traumatic brain injuries, and neurodegenerative diseases are becoming more prevalent, necessitating effective rehabilitation solutions. For instance, the World Health Organization indicates that stroke is a leading cause of disability worldwide. This growing patient population is expected to fuel demand for neurorehabilitation devices, which are projected to reach a market value of 0.86 USD Billion in 2024, with expectations of growth as the global healthcare system adapts to these challenges.

Innovations in technology are significantly influencing the Global Neurorehabilitation Devices Market Industry. The integration of robotics, artificial intelligence, and virtual reality into rehabilitation practices enhances the efficacy of treatment protocols. For example, robotic exoskeletons and smart rehabilitation devices provide personalized therapy, improving patient outcomes. As these technologies evolve, they are likely to attract investment and interest from healthcare providers, thereby expanding market opportunities. The anticipated growth trajectory suggests that the market could reach 1.76 USD Billion by 2035, reflecting a compound annual growth rate of 6.72% from 2025 to 2035.

The global demographic shift towards an aging population is a critical driver for the Global Neurorehabilitation Devices Market Industry. As individuals age, the likelihood of experiencing neurological disorders increases, leading to a higher demand for rehabilitation solutions. Additionally, older adults often require more healthcare services, which translates into increased expenditure on neurorehabilitation devices. Countries with significant aging populations, such as Japan and Italy, are likely to see substantial market growth as they invest in advanced rehabilitation technologies to cater to their elderly citizens. This trend underscores the importance of addressing the needs of this demographic.

There is a growing awareness and acceptance of neurorehabilitation practices among healthcare professionals and patients, which is driving the Global Neurorehabilitation Devices Market Industry. Educational campaigns and professional training programs are enhancing understanding of the benefits of neurorehabilitation devices. As patients become more informed about their treatment options, they are more likely to seek out these advanced solutions. This shift in perception is expected to lead to increased demand for neurorehabilitation devices, thereby supporting market growth in the coming years.

By Region, the study provides the market insights into North America, Europe, Asia-Pacific, and Rest of the World. North America Neurorehabilitation Devices market accounted for USD 6.3 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the increasing incidence rate of neurological diseases, the increasing geriatric population, and the sophisticated and equipped healthcare infrastructure.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3:  NEUROREHABILITATION DEVICES MARKET SHARE BY REGION 2021 (%)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Neurorehabilitation Devices market is expected to grow in market share during the forecast period owing to the presence of prominent players in the region and the increased adoption rate of these services. An increased patient base with neurological disorders will also add to the regional growth. Further, the Germany Neurorehabilitation Devices market held the largest market share, and the UK Neurorehabilitation Devices market was the fastest growing market in the European region

The Asia-Pacific Neurorehabilitation Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. Factors such as improving healthcare infrastructure, rising awareness of neurorehabilitation devices, and the increased expansion of prominent players in the region will account for a wider segmental growth of the region. Moreover, China Neurorehabilitation Devices market held the largest market share, and the India Neurorehabilitation Devices market was the fastest growing market in the Asia-Pacific region

For instance, India Neurorehabilitation Devices market is expected to grow significantly during the forecast period owing to expanded infrastructure within the region combined with rising disposable income. Additionally, various international players are setting up shop in India owing to the rising prevalence of neurological diseases and the rising number of geriatric populations, which will add to the regional growth.  

Major market players are expected to invest heavily with their research and development departments to widen their consumer base and increase revenues for the neurorehabilitation devices market. Market leaders are focused on expanding their presence by participating in various development activities such as market developments including new product launches, mergers and acquisitions, increased investments, and collaboration with other organizations. Additionally, prominent leaders are focused on expanding the neurorehabilitation devices by offering their devices at a cost-effective nature.  

Another primary strategy that resides within the neurorehabilitation devices industry is by reducing operational costs and benefitting increased production. During the forecast period the neurorehabilitation devices industry is expected to cater a wider end-use vertical by offering products that come with increased functionalities and capabilities. The neurorehabilitation devices market major player such as Abbott Laboratories (US), Ekso Bionics Holdings Inc (US), Helius Medical Technologies (US), Hocoma AG (Switzerland) and others are working to increase their consumer base by introducing new products towards their portfolios.

High-quality product development and manufacture are Hocoma AG's goals while capturing a wider competitive base. Their products have a high level of safety and include a spectrum of user-friendliness that benefits both patients and therapists. Their products adhere to all applicable international standards and medical legislation. While working closely with its partners in research and sales, Hocoma tries to understand the needs of their customers by guaranteeing the security of their products.

Medtronic produces astonishing things by combining data, artificial intelligence, and their extensive understanding of the human body. They are focused on their manufacturing by using data-driven insights to improve care by customizing therapies in real-time significantly. Additionally, Medtronic is focused on providing the edge of technology advances patient care by reinventing robotic-assisted surgery to reach more patients with the highest levels of precision and predictability. They combine cutting-edge technology, a thorough understanding of the human body, and cutting-edge medical science to develop novel treatments.